Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
7.48
-0.29 (-3.73%)
At close: Sep 12, 2025, 4:00 PM EDT
7.52
+0.04 (0.53%)
After-hours: Sep 12, 2025, 4:57 PM EDT

Lifecore Biomedical Stock Forecast

Stock Price Forecast

The 2 analysts that cover Lifecore Biomedical stock have a consensus rating of "Buy" and an average price target of $8.00, which forecasts a 6.95% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $10.

Price Target: $8.00 (+6.95%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$6.00$8.00$10$10
Change-19.79%+6.95%+33.69%+33.69%
* Price targets were last updated on Jan 3, 2025.

Analyst Ratings

The average analyst rating for Lifecore Biomedical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy111111
Buy011111
Hold222222
Sell000000
Strong Sell000000
Total344444

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Keybanc
Keybanc
Hold
Initiates
n/a
HoldInitiatesn/an/aSep 4, 2025
William Blair
William Blair
Buy
Initiates
n/a
BuyInitiatesn/an/aMay 21, 2025
Stephens & Co.
Stephens & Co.
Hold
Reiterates
$6
HoldReiterates$6-19.79%Jan 3, 2025
Craig-Hallum
Craig-Hallum
Strong Buy
Maintains
$8$10
Strong BuyMaintains$8$10+33.69%Nov 22, 2024
Craig-Hallum
Craig-Hallum
Strong Buy
Initiates
$8
Strong BuyInitiates$8+6.95%Sep 5, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
134.94M
from 128.87M
Increased by 4.71%
Revenue Next Year
149.75M
from 134.94M
Increased by 10.98%
EPS This Year
-0.74
from -1.27
EPS Next Year
-0.44
from -0.74
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMay 30, 2021May 29, 2022May 28, 2023May 26, 2024May 25, 2025May 25, 2026May 25, 2027
Revenue
100.87M111.27M103.27M128.26M128.87M134.94M149.75M
Revenue Growth
-36.98%10.31%-7.19%24.20%0.47%4.71%10.98%
EPS
-1.10-3.97-3.320.33-1.27-0.74-0.44
EPS Growth
-------
Forward PE
-------
No. Analysts
-----54
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030
High144.1M157.8M
Avg134.9M149.8M
Low126.6M139.6M

Revenue Growth

Revenue Growth20262027202820292030
High
11.8%
17.0%
Avg
4.7%
11.0%
Low
-1.7%
3.4%

EPS Forecast

EPS202620272028
High-0.64-0.45
Avg-0.74-0.44
Low-0.82-0.42

EPS Growth

EPS Growth202620272028
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.